Cargando…
Privacy preserving validation for multiomic prediction models
Reproducibility of results obtained using ribonucleic acid (RNA) data across labs remains a major hurdle in cancer research. Often, molecular predictors trained on one dataset cannot be applied to another due to differences in RNA library preparation and quantification, which inhibits the validation...
Autores principales: | Ahmed, Talal, Carty, Mark A, Wenric, Stephane, Dry, Jonathan R, Salahudeen, Ameen A, Khan, Aly A, Lefkofsky, Eric, Stumpe, Martin C, Pelossof, Raphael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116386/ https://www.ncbi.nlm.nih.gov/pubmed/35388408 http://dx.doi.org/10.1093/bib/bbac110 |
Ejemplares similares
-
Multiomics integration-based molecular characterizations of COVID-19
por: Li, Chuan-Xing, et al.
Publicado: (2021) -
Multiomics dynamic learning enables personalized diagnosis and prognosis for pancancer and cancer subtypes
por: Lu, Yuxing, et al.
Publicado: (2023) -
DLRAPom: a hybrid pipeline of Optimized XGBoost-guided integrative multiomics analysis for identifying targetable disease-related lncRNA–miRNA–mRNA regulatory axes
por: Shen, Chen, et al.
Publicado: (2022) -
Validation of transcriptome signature reversion for drug repurposing in oncology
por: Koudijs, Karel K M, et al.
Publicado: (2022) -
Systematic optimization of host-directed therapeutic targets and preclinical validation of repositioned antiviral drugs
por: Xie, Dafei, et al.
Publicado: (2022)